Literature DB >> 20154640

Very important pharmacogene summary: thiopurine S-methyltransferase.

Liewei Wang1, Linda Pelleymounter, Richard Weinshilboum, Julie A Johnson, Joan M Hebert, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20154640      PMCID： PMC3086840          DOI： 10.1097/FPC.0b013e3283352860

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  46 in total

1.  Characterization of three new VNTR alleles in the promoter region of the TPMT gene.

Authors:  S Alves; F Ferreira; M J Prata; A Amorim
Journal:  Hum Mutat       Date:  2000-01       Impact factor: 4.878

2.  Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.

Authors:  H L McLeod; S C Pritchard; J Githang'a; A Indalo; M M Ameyaw; R H Powrie; L Booth; E S Collie-Duguid
Journal:  Pharmacogenetics       Date:  1999-12

3.  Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

Authors:  W E Evans; Y Y Hon; L Bomgaars; S Coutre; M Holdsworth; R Janco; D Kalwinsky; F Keller; Z Khatib; J Margolin; J Murray; J Quinn; Y Ravindranath; K Ritchey; W Roberts; Z R Rogers; D Schiff; C Steuber; F Tucci; N Kornegay; E Y Krynetski; M V Relling
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

4.  Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.

Authors:  H L Tai; E Y Krynetski; E G Schuetz; Y Yanishevski; W E Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

Authors:  D M Otterness; C L Szumlanski; T C Wood; R M Weinshilboum
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.

Authors:  L Yan; S Zhang; B Eiff; C L Szumlanski; M Powers; J F O'Brien; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2000-08       Impact factor: 6.875

7.  Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.

Authors:  D Otterness; C Szumlanski; L Lennard; B Klemetsdal; J Aarbakke; J O Park-Hah; H Iven; K Schmiegelow; E Branum; J O'Brien; R Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1997-07       Impact factor: 6.875

8.  Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.

Authors:  H L Tai; E Y Krynetski; C R Yates; T Loennechen; M Y Fessing; N F Krynetskaia; W E Evans
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

9.  Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.

Authors:  Fang Li; Liewei Wang; Rebecca J Burgess; Richard M Weinshilboum
Journal:  Pharmacogenet Genomics       Date:  2008-12       Impact factor: 2.089

10.  Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1.

Authors:  D Lee; C Szumlanski; J Houtman; R Honchel; K Rojas; J Overhauser; E D Wieben; R M Weinshilboum
Journal:  Drug Metab Dispos       Date:  1995-03       Impact factor: 3.922
View more
  18 in total

1.  Pharmacogenomics and bioinformatics: PharmGKB.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

Review 2.  Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.

Authors:  Wen-ying Shu; Jia-li Li; Xue-ding Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

3.  High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Mireya Ramirez-Florencio; Silvia Jiménez-Morales; Rosa Elda Barbosa-Cobos; Daniela Josabeth López-Cano; Julian Ramírez-Bello
Journal:  Clin Rheumatol       Date:  2017-12-20       Impact factor: 2.980

Review 4.  Germline oncopharmacogenetics, a promising field in cancer therapy.

Authors:  Chiara Pesenti; Milena Gusella; Silvia M Sirchia; Monica Miozzo
Journal:  Cell Oncol (Dordr)       Date:  2015-01-09       Impact factor: 6.730

5.  Nomenclature for alleles of the thiopurine methyltransferase gene.

Authors:  Malin L Appell; Jonathan Berg; John Duley; William E Evans; Martin A Kennedy; Lynne Lennard; Tony Marinaki; Howard L McLeod; Mary V Relling; Elke Schaeffeler; Matthias Schwab; Richard Weinshilboum; Allen E J Yeoh; Ellen M McDonagh; Joan M Hebert; Teri E Klein; Sally A Coulthard
Journal:  Pharmacogenet Genomics       Date:  2013-04       Impact factor: 2.089

6.  The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.

Authors:  Doreen Z Mhandire; Andrew K L Goey
Journal:  Mol Diagn Ther       Date:  2022-02-03       Impact factor: 4.074

7.  Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?

Authors:  Jaime L Lopes; Kimberley Harris; Mary Beth Karow; Sandra E Peterson; Michelle L Kluge; Katrina E Kotzer; Guilherme S Lopes; Nicholas B Larson; Suzette J Bielinski; Steven E Scherer; Liewei Wang; Richard M Weinshilboum; John L Black; Ann M Moyer
Journal:  J Mol Diagn       Date:  2022-01-15       Impact factor: 5.341

8.  Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes.

Authors:  Berta Almoguera; Lyam Vazquez; John J Connolly; Jonathan Bradfield; Patrick Sleiman; Brendan Keating; Hakon Hakonarson
Journal:  Front Genet       Date:  2014-05-12       Impact factor: 4.599

Review 9.  Assessment of Thiopurine-based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia.

Authors:  F Azimi; M Jafariyan; S Khatami; Y Mortazavi; M Azad
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20

Review 10.  Implementation and utilization of genetic testing in personalized medicine.

Authors:  Noura S Abul-Husn; Aniwaa Owusu Obeng; Saskia C Sanderson; Omri Gottesman; Stuart A Scott
Journal:  Pharmgenomics Pers Med       Date:  2014-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.